Pfizer: Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections
| Name: |
Pfizer: Diagnosis and Diagnostic Tests for Metallo-β-Lactamase (MBL) Producing Bacterial Infections Application deadline: 18/04/24 |
|---|---|
| General description: |
Foster healthcare professional education to support them in making evidence-informed decisions in the diagnosis and management of patients with Metallo-β-Lactamase(MBL) producing bacterial infections. Funding: up to $100K https://www.ra.trdf.co.il/files/Producing Bacterial Infections IME.pdf |
| Source: | Foreign |
| Participating Countries: | All Countries, |
| Budget: | up to $100K |
| Contact person: | Robi, 2152, robertg@trdf.technion.ac.il; iris 1272, irisbr@technion.ac.il; Luba, lubak@technion.ac.il |
| Fields: | Life Sciences and medicine |
| Type of fund: | The fund is not a competitive fund |
| Related fund and profiles: | Pfizer ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner) |